• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dose-response is alive and well.

作者信息

DeVita V T

出版信息

J Clin Oncol. 1986 Aug;4(8):1157-9. doi: 10.1200/JCO.1986.4.8.1157.

DOI:10.1200/JCO.1986.4.8.1157
PMID:3525764
Abstract
摘要

相似文献

1
Dose-response is alive and well.剂量反应关系依然存在且状况良好。
J Clin Oncol. 1986 Aug;4(8):1157-9. doi: 10.1200/JCO.1986.4.8.1157.
2
Dose intensity: a critique of a critical review.
J Clin Oncol. 1989 May;7(5):681-4. doi: 10.1200/JCO.1989.7.5.681.
3
Dose intensity in chemotherapy of metastatic breast cancer.转移性乳腺癌化疗中的剂量强度。
J Clin Oncol. 1985 Jun;3(6):889-91. doi: 10.1200/JCO.1985.3.6.889.
4
More is better.
J Clin Oncol. 1988 Sep;6(9):1365-7. doi: 10.1200/JCO.1988.6.9.1365.
5
Scientific misconduct in cancer clinical trials.
S Afr Med J. 2001 Aug;91(8):614-5.
6
Chemotherapy for advanced aggressive lymphoma: more is better ...isn't it?
J Clin Oncol. 1990 Jun;8(6):952-5. doi: 10.1200/JCO.1990.8.6.952.
7
[Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].[化疗中剂量强度的重要性——早期乳腺癌辅助化疗的经验教训]
Rinsho Ketsueki. 2009 Apr;50(4):276-81.
8
[Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day].
Acta Clin Belg Suppl. 1986;11:41-8.
9
Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors.
J Clin Oncol. 1986 Mar;4(3):442-4. doi: 10.1200/JCO.1986.4.3.442.
10
[The use of high-dose chemotherapy in the treatment of breast cancer].
Med Clin (Barc). 1996 Jun 8;107(2):56-8.

引用本文的文献

1
Effect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cells.磁纳米粒子对甘草素诱导 Raji 细胞凋亡和细胞周期的影响。
Int J Nanomedicine. 2012;7:789-98. doi: 10.2147/IJN.S28089. Epub 2012 Feb 14.
2
Magnetic Fe₃O₄ nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells.磁性 Fe₃O₄ 纳米粒子与化疗药物协同作用诱导淋巴瘤细胞凋亡。
Int J Nanomedicine. 2010 Nov 19;5:999-1004. doi: 10.2147/IJN.S14957.
3
Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial.
成人软组织肉瘤强化辅助IFADIC化疗：一项前瞻性随机可行性试验
Sarcoma. 2000;4(4):151-60. doi: 10.1155/2000/126837.
4
The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anticancer agents.在合理设计的基于靶点的抗癌药物新时代追求癌症治疗的最佳疗效。
Drugs. 2000;60 Suppl 1:1-14; discussion 41-2. doi: 10.2165/00003495-200060001-00001.
5
Dose intensity analysis in advanced ovarian cancer patients.晚期卵巢癌患者的剂量强度分析。
Br J Cancer. 1993 Jan;67(1):190-7. doi: 10.1038/bjc.1993.33.
6
Optimizing the effectiveness of hematopoietic growth factors.优化造血生长因子的有效性。
J Clin Immunol. 1994 Jul;14(4):215-23. doi: 10.1007/BF01552307.
7
Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.肿瘤学中的治疗药物监测。抗肿瘤治疗中的问题与潜力。
Clin Pharmacokinet. 1987 Oct;13(4):205-27. doi: 10.2165/00003088-198713040-00001.
8
Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensity.
Blut. 1988 Jun;56(6):241-8. doi: 10.1007/BF00320282.
9
Clinical pharmacokinetics-pharmacodynamics of anticancer drugs.
Clin Pharmacokinet. 1989 Jun;16(6):327-36. doi: 10.2165/00003088-198916060-00001.
10
Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group.
Med Oncol Tumor Pharmacother. 1989;6(3):207-12. doi: 10.1007/BF02985192.